carbavance
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Jul 1, 2014 (NCT02168946)
Timeline
Indications
Mechanism of action
- Beta LactamaseINHIBITOR
bla(tem-2) inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- carbavance
- carbavance
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02687906 | Phase 1 | Jul 1, 2016 | Department of Health and Human Services, Sponsor GmbH, The Medicines Company |
| NCT02166476 | Phase 3 | Nov 1, 2014 | Department of Health and Human Services, Sponsor GmbH, The Medicines Company, Wayne State University |
| NCT02168946 | Phase 3 | Jul 1, 2014 | Department of Health and Human Services, Sponsor GmbH, The Medicines Company, Wayne State University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Department of Health and Human Services | Government | 3 | 0 | 2 | 2014 |
| Sponsor GmbH | Academic/Hospital | 3 | 0 | 2 | 2014 |
| The Medicines Company | For profit | 3 | 3 | 2 | 2014 |
| Wayne State University | Academic/Hospital | 2 | 0 | 1 | 2014 |
4 organizations
Page 1 / 1